Citigroup
RMD icon

Citigroup’s ResMed RMD Stock Holding History

Citigroup’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,600
Closed -$5.85M – 5901
2024
Q4 		$5.85M Sell
25,600
-125,800
-83% -$30.3M ﹤0.01% 1800
2024
Q3 		$37M Buy
+151,400
New +$33.8M 0.02% 658
2022
Q2 		– Sell
-10,000
Closed -$2.42M – 6590
2022
Q1 		$2.42M Buy
+10,000
New +$2.42M ﹤0.01% 2212
2021
Q1 		– Sell
-2,700
Closed -$574K – 7193
2020
Q4 		$574K Sell
2,700
-4,600
-63% -$917K ﹤0.01% 4075
2020
Q3 		$1.25M Sell
7,300
-300
-4% -$55.4K ﹤0.01% 3074
2020
Q2 		$1.46M Sell
7,600
-4,600
-38% -$753K ﹤0.01% 3153
2020
Q1 		$1.8M Buy
12,200
+100
+0.8% +$15.9K ﹤0.01% 2586
2019
Q4 		$1.88M Sell
12,100
-26,200
-68% -$3.78M ﹤0.01% 3054
2019
Q3 		$5.17M Sell
38,300
-4,600
-11% -$603K ﹤0.01% 1904
2019
Q2 		$5.24M Buy
42,900
+10,300
+32% +$1.14M ﹤0.01% 1934
2019
Q1 		$3.39M Sell
32,600
-2,000
-6% -$206K ﹤0.01% 2137
2018
Q4 		$3.94M Buy
+34,600
New +$3.71M ﹤0.01% 2036
2013
Q3 		– Sell
-28,100
Closed -$1.27M – 6949
2013
Q2 		$1.27M Buy
+28,100
New +$1.33M ﹤0.01% 2699

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup's RMD Position: Q1 2026 in Review

Citigroup increased its ResMed (RMD) stake by 54% in Q1 2026, buying an estimated $34M and bringing the position to 390,082 shares worth $87.6M. The position accounts for 0.04% of the portfolio, ranked #446.

Citigroup first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Citigroup held 390,082 shares of ResMed worth $87.6M as of Q1 2026.
  • Citigroup bought 136,267 ResMed shares in Q1 2026, an estimated $34M.
  • ResMed made up 0.04% of Citigroup's portfolio in Q1 2026, its #446 holding.
  • Citigroup first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.